Vaccination

FDA experts weigh authorizing Novavax COVID-19 vaccine in US

A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...

Vaccination

China's bet on homegrown mRNA vaccines holds back nation

China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19.

Diseases, Conditions, Syndromes

Expert discusses progress of mRNA vaccines

Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against COVID-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered ...

page 14 from 33